Biopharma has promised $290B+ in US manufacturing in the past six monthsnews2025-08-21T17:02:22+00:00August 21st, 2025|Endpoints News|
FDA approves Ionis’ RNA-targeting therapy to treat rare disease that causes swelling attacksnews2025-08-21T16:58:21+00:00August 21st, 2025|Endpoints News|
Trump’s ‘most favored nation’ policy will apply to EU generics news2025-08-21T16:08:20+00:00August 21st, 2025|Endpoints News|
Prader-Willi syndrome is not a zero-sum game. There’s room for many winnersnews2025-08-21T11:00:48+00:00August 21st, 2025|Endpoints News|
HHS staffers blame RFK Jr. for ‘deliberate destruction’ of trustnews2025-08-20T19:14:24+00:00August 20th, 2025|Endpoints News|
Enanta files patent suit against Pfizer in Europenews2025-08-20T18:57:54+00:00August 20th, 2025|Endpoints News|
Nucleus RadioPharma taps former FDA commissioner as CEO news2025-08-20T15:49:34+00:00August 20th, 2025|Endpoints News|
With $42M, Jazz turns to Copenhagen biotech to build out epilepsy pipelinenews2025-08-20T14:37:19+00:00August 20th, 2025|Endpoints News|
Leading pediatrics group breaks with RFK Jr. on Covid vaccinesnews2025-08-20T07:03:18+00:00August 20th, 2025|Endpoints News|
HHS seeks to dismiss Rhode Island lawsuit over reorganization plansnews2025-08-19T19:07:21+00:00August 19th, 2025|Endpoints News|
